CD274 and adenocarcinoma: Like other studies that demonstrated variability in TPS among subtypes of cancers, our results revealed that PD-L1 expression was found to be significantly higher (p < 0.01) in adenocarcinoma (67.7%) compared to SCC (48.2%).